HLS Therapeutics Inc HLTRF

Morningstar Rating
$2.60 −0.13 (4.76%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

HLTRF is trading at a LOCK|<CVV premium.
Price
$2.60
Fair Value
LOCK|qNP$^gH
Uncertainty
LOCK|H%
1-Star Price
LOCK|!!$^<g!
5-Star Price
LOCK|!r#!!s
Economic Moat
LOCK|nW
Capital Allocation
—

Trading Information

Previous Close Price
$2.73
Day Range
$2.46–2.60
52-Week Range
$2.46–3.47
Bid/Ask
$2.33 / $2.71
Shares Outstanding
30.94M
Market Cap
$81.31M
Volume/Avg
8,800 / 3,558

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
1.42
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
3.71%

Company Profile

HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company's products include Clozaril, Vascepa, CSAN Pronto, and others. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States, and the Rest of world, with the majority of its revenue generated from Canada.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
86

Valuation

Metric
HLTRF
Price/Earnings (Normalized)
—
Price/Book Value
1.58
Price/Sales
1.42
Price/Cash Flow
5.66
Price/Earnings
HLTRF

Financial Strength

Metric
HLTRF
Quick Ratio
0.76
Current Ratio
1.05
Interest Coverage
−1.37
Quick Ratio
HLTRF

Profitability

Metric
HLTRF
Return on Assets (Normalized)
−4.36%
Return on Equity (Normalized)
−9.96%
Return on Invested Capital (Normalized)
−2.78%
Return on Assets
HLTRF

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
LOCK|&C&L&V&%LOCK|?zGY$72B
Teva Pharmaceutical Industries Ltd
TEVA
LOCK|x%c&PPJLOCK|tNlbT$51B
Haleon PLC ADR
HLN
LOCK|$#@$htLOCK|>mS$40B
Zoetis Inc Class A
ZTS
LOCK|<jW#^?%<LOCK|n%$34B
Viatris Inc
VTRS
LOCK|!?#$BRLOCK|&qQ$24B
Elanco Animal Health Inc
ELAN
LOCK|#^LOCK|lm$13B
Dr Reddy's Laboratories Ltd ADR
RDY
LOCK|<@YDJHLOCK|wS%$12B
Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
LOCK|?l#&p@gLOCK|Tdg$5B
Perrigo Co PLC
PRGO
LOCK|%>XCQzLOCK|&N$2B
Prestige Consumer Healthcare Inc
PBH
LOCK|%fRFq&xLOCK|&rXS$2B

Sponsor Center